Marker Therapeutics (MRKR) Debt Ratio (2010 - 2023)

Marker Therapeutics (MRKR) has 12 years of Debt Ratio data on file, last reported at 0.0 in Q1 2023.

• Debt Ratio for Q1 2023 came in at 0.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was 0.0 (changed N/A YoY), and the FY2022 annual result was 0.07, changed N/A from the prior year.
• Debt Ratio fell to 0.0 in Q1 2023 per MRKR's latest filing, from 0.07 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.15 in Q2 2022 and troughed at 0.0 in Q4 2019.
• A 3-year average of 0.04 and a median of 0.0 in 2019 frame the typical range for Debt Ratio.
• On a YoY basis, Debt Ratio climbed as much as 15.19% in 2019 and fell as far as 93.65% in 2019.
• A 3-year view of Debt Ratio shows it stood at 0.0 in 2019, then soared by 10761.17% to 0.07 in 2022, then tumbled by 95.2% to 0.0 in 2023.
• Business Quant data shows MRKR's Debt Ratio at 0.0 in Q1 2023, 0.07 in Q4 2022, and 0.12 in Q3 2022.